Clinical Trials in Tennessee

Showing 13081-13100 of 20,239 trials

A Study for Patients With Acute Leukemia

NCT01214655

This study is a multicenter, nonrandomized, open-label, dose-escalation with intra-patient dose-escalation, Phase 1 study of intravenous LY2523355 to determine the dose of LY2523355 that can be safely administered to participants with acute leukemia. Part A and Part B are dose escalation of two schedules in participants with acute leukemia. Parts A and B will enroll concurrently. Part C is a dose expansion for each schedule in participants with acute myeloblastic leukemia (AML).

Acute Leukemia

Eli Lilly and Company33 participantsStarted Jun 2008

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 129 miles

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

NCT01597193

The purpose of this study is to determine the safety, tolerability and pharmacokinetics of enzalutamide alone and in combination with anastrozole, or exemestane, or fulvestrant in patients with incurable breast cancer.

Breast Cancer

Pfizer101 participantsStarted Apr 2012

Aurora, Colorado, United States • Aurora, Colorado, United States • Aurora, Colorado, United States +14 more locations

A Study for Patients With Acute Leukemia

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Find Trials by Condition in Tennessee

Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump

Operative Versus Nonoperative Treatment of Humeral Shaft Fractures: A Prospective Cohort Comparison Study

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

Melody® Transcatheter Pulmonary Valve Post-Approval Study

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants

Fenzian Asthma Multicenter Outcomes Study

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Kybella With Triamcinolone